Avisa Breathtest News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Avisa Diagnostics Announces Non-Brokered Private Placement of Common Shares NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avisa Diagnostics Inc. a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, today announced that it intends to conduct a non-brokered private placement of 1,390,000 common shares of the Company to raise … NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avisa Diagnostics Inc. (CSE:AVBT) (“ Avisa ” or the “ Company ”), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, today announced that it intends to conduct a non-brokered private placement (the “ Offering ”) of 1,390,000 common shares (“ Common Shares ”) of the Co

United statesAvisa breathtestDavids josephLaurie doyleRaimund gabrielMc servicesAvisa diagnostics incCanadian securities exchangeCommon shares of the companyCanadian securitiesCommon sharesUnited states securities actInvestigational device exemptionChief executive officerMedia contactsMarket regulator